Document Detail

Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
MedLine Citation:
PMID:  6229579     Owner:  NLM     Status:  MEDLINE    
Enriched subpopulations of peripheral blood mononuclear cells from patients with myasthenia gravis and from normal control individuals were tested for proliferative ability in the autologous mixed lymphocyte reactions. Myasthenia gravis patients were studied at various phases of therapy. Longitudinal patient populations were studied. Purified T cells from untreated patients with active myasthenia gravis demonstrated enhanced proliferative responses when co-cultured with nonmodified autologous non-T cells. Furthermore, treatment by thymectomy with or without prior plasmapheresis was associated with a consequent normalization of the autologous reaction. The enhanced autologous mixed lymphocyte reaction in the pre-treatment group of myasthenia gravis patients was significantly different from the post-treatment and normal control groups (Stimulation Index, p less than 0.01 and p less than 0.02, respectively). This difference in activity was also confirmed in a longitudinal study of 10 patients followed pre- and post-treatment (Stimulation Index, p less than 0.02). There was no difference between the responses of post-treatment patients and normal control individuals. There was no evidence of altered T cell responsiveness or non-T cell stimulation, as measured by the allogeneic mixed lymphocyte reaction or by mitogen-induced lymphocyte proliferation, between pretreatment and post-treatment patients as compared to controls. The responses were not affected by serum substitution experiments whereby myasthenic responder T cells were co-cultured with pooled normal human sera. Other parameters studied included clinical status, anti-acetylcholine receptor antibody levels, and thymic pathology. An intriguing connection between abnormalities in the thymic cell populations and the autoaggressive state in myasthenia may be reflected by the in vitro autologous mixed lymphocyte reaction.
S J Greenberg; C W Olanow; D V Dawson; B Crane; A D Roses
Related Documents :
7697959 - D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable com...
17670509 - Thymoma is associated with relapse of symptoms after transsternal thymectomy for myasth...
8217819 - Subclinical autonomic dysfunction in patients with hodgkin's disease and non-hodgkin's ...
12821509 - Clinical correlates with anti-musk antibodies in generalized seronegative myasthenia gr...
17449259 - Head and neck cancer, epidemiology and histological aspects - part 1: a decade's result...
6940079 - Pemphigus-like mucosal lesions: a side effect of penicillamine therapy.
17579839 - Knee-laxity measurements examined by a left-hand- and a right-hand-dominant physiothera...
6223769 - Mesangial iga nephropathy: detection of defective reticulophagocytic function in vivo.
2961409 - Speech timing in parkinson's and huntington's disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of immunology (Baltimore, Md. : 1950)     Volume:  132     ISSN:  0022-1767     ISO Abbreviation:  J. Immunol.     Publication Date:  1984 Mar 
Date Detail:
Created Date:  1984-03-23     Completed Date:  1984-03-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985117R     Medline TA:  J Immunol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1229-36     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Autoantibodies / analysis
Lymphocyte Activation
Lymphocyte Culture Test, Mixed*
Middle Aged
Myasthenia Gravis / immunology*,  pathology,  therapy
Receptors, Cholinergic / immunology
T-Lymphocytes / immunology
Thymus Gland / pathology
Grant Support
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Autoantibodies; 0/Receptors, Cholinergic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies.
Next Document:  Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.